Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Bolni Nagalo to Humans

This is a "connection" page, showing publications Bolni Nagalo has written about Humans.

 
Connection Strength
  
 
 
0.423
  
  1. Nagalo BM, Zhou Y, Loeuillard EJ, Dumbauld C, Barro O, Elliott NM, Baker AT, Arora M, Bogenberger JM, Meurice N, Petit J, Uson PLS, Aslam F, Raupach E, Gabere M, Basnakian A, Simoes CC, Cannon MJ, Post SR, Buetow K, Chamcheu JC, Barrett MT, Duda DG, Jacobs B, Vile R, Barry MA, Roberts LR, Ilyas S, Borad MJ. Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers. Hepatology. 2023 06 01; 77(6):1943-1957.
    View in: PubMed
    Score: 0.034
  2. Zhang Y, Nagalo BM. Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We? Front Immunol. 2022; 13:898631.
    View in: PubMed
    Score: 0.034
  3. Wongjarupong N, Oli S, Sanou M, Djigma F, Kiba Koumare A, Yonli AT, Hassan MA, Mara K, Harmsen WS, Therneau T, Barro O, Vodounhessi G, Sawadogo S, Chamcheu JC, Simpore J, Roberts LR, Nagalo BM. Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study. Am J Trop Med Hyg. 2021 02 22; 104(4):1577-1581.
    View in: PubMed
    Score: 0.031
  4. Eko Mba JM, Bisseye C, Mombo LE, Ntsame Ndong JM, Mbina Ekayeng SC, Bengone C, M'batchi B, Nagalo BM. Assessment of rapid diagnostic tests and fourth-generation Enzyme-Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first-time blood donors in Libreville (Gabon). J Clin Lab Anal. 2019 Mar; 33(3):e22824.
    View in: PubMed
    Score: 0.026
  5. Bisseye C, Mombo LE, Bie SMM, Edou A, Eko-Mba JM, Etho-Mengue JC, Mbacky K, Mongo-Delis A, M'batchi B, Nagalo BM. Trends of blood-borne infectious diseases in a rural blood donation center of southeast Gabon (Koula-Moutou). Pan Afr Med J. 2018; 31:81.
    View in: PubMed
    Score: 0.026
  6. Eko Mba JM, Bisseye C, Ntsame Ndong JM, Mombo LE, Bengone C, Mouelet Migolet G, M'batchi B, Kosiorek HE, Butterfield RJ, Roberts LR, Borad MJ, Nagalo BM. Prevalent hepatitis B surface antigen among first-time blood donors in Gabon. PLoS One. 2018; 13(4):e0194285.
    View in: PubMed
    Score: 0.025
  7. Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebi? YK, Kiba A, Dahourou H, Ouattara S, Nikiema JB, Moret R, Zongo JD, Simpore J. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health. 2012 Feb; 17(2):247-53.
    View in: PubMed
    Score: 0.016
  8. Nagalo MB, Sanou M, Bisseye C, Kabor? MI, Nebie YK, Kienou K, Kiba A, Dahourou H, Ouattara S, Zongo JD, Simpor? J. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus. 2011 Oct; 9(4):419-24.
    View in: PubMed
    Score: 0.016
  9. Nagalo BM, Bisseye C, Sanou M, Nebi? YK, Kiba A, Kienou K, Zongo JD, Simpor? J. [Molecular diagnosis of acquired human immunodeficiency virus (HIV) in pooled plasma from blood donors at the Regional Blood Transfusion Center in Ouagadougou, Burkina Faso]. Med Trop (Mars). 2011 Apr; 71(2):137-41.
    View in: PubMed
    Score: 0.015
  10. Traore L, Triande MN, Zongo SV, Ouattara AK, Savadogo M, Nignan N, Traore MS, Compaore TR, Ilboudo DP, Sagna T, Traore IM, Diarra B, Yonli AT, Nagalo BM, Bambara AT, Sombie RA, Djigma FW, Simpore J. Association between extracellular matrix protein 1 (ECM1) gene polymorphisms (rs3834087 and rs3754217) and Hepatitis B Virus evolution in an African cohort. Cell Mol Biol (Noisy-le-grand). 2025 Jan 12; 70(12):36-44.
    View in: PubMed
    Score: 0.010
  11. Albadawi H, Zhang Z, Keum H, Cevik E, Nagalo BM, Gunduz S, Kita H, Oklu R. Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics. Adv Mater. 2024 Nov; 36(45):e2406080.
    View in: PubMed
    Score: 0.010
  12. Hartupee C, Nagalo BM, Chabu CY, Tesfay MZ, Coleman-Barnett J, West JT, Moaven O. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. Front Immunol. 2024; 15:1287459.
    View in: PubMed
    Score: 0.009
  13. Boateng ST, Roy T, Agbo ME, Mahmud MA, Banang-Mbeumi S, Chamcheu RN, Yadav RK, Bramwell M, Pham LK, Dang DD, Jackson KE, Nagalo BM, Hill RA, Efimova T, Fotie J, Chamcheu JC. Multifaceted approach toward mapping out the anticancer properties of small molecules via in?vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing. Chem Biol Drug Des. 2024 01; 103(1):e14418.
    View in: PubMed
    Score: 0.009
  14. Boateng ST, Roy T, Torrey K, Owunna U, Banang-Mbeumi S, Basnet D, Niedda E, Alexander AD, Hage DE, Atchimnaidu S, Nagalo BM, Aryal D, Findley A, Seeram NP, Efimova T, Sechi M, Hill RA, Ma H, Chamcheu JC, Murru S. Synthesis, in silico modelling, and in?vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents. J Enzyme Inhib Med Chem. 2023 Dec; 38(1):2205042.
    View in: PubMed
    Score: 0.009
  15. Marin LP, Presley JH, Noori K, McKinstry D, Dawson B, Sexton K, Peterson E, Harrington SE, Gardner JM, Nagalo BM, Montzavi-Karbassi B, Post SR, Nicholas RW, Kelly T. Partnership in Cancer Research (PCAR) Program Increases Medical Student Knowledge and Confidence to Perform Cancer Research. J Cancer Educ. 2024 Apr; 39(2):111-117.
    View in: PubMed
    Score: 0.009
  16. Zongo SV, Djigma FW, Yonli AT, Sorgho PA, Nagalo BM, Traore L, Somda D, Amegnona LJ, Languie E, Some CCB, Sia LMJ, Sourabie IB, Sombie RA, Serme AK, Obiri-Yeboah D, Simpore J. Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso. Mol Biol Rep. 2023 Jun; 50(6):5039-5047.
    View in: PubMed
    Score: 0.009
  17. Roy T, Banang-Mbeumi S, Boateng ST, Ruiz EM, Chamcheu RN, Kang L, King JA, Walker AL, Nagalo BM, Kousoulas KG, Esnault S, Huang S, Chamcheu JC. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation. Front Immunol. 2022; 13:1075804.
    View in: PubMed
    Score: 0.009
  18. Uson Junior PLS, Majeed U, Yin J, Botrus G, Sonbol MB, Ahn DH, Starr JS, Jones JC, Babiker H, Inabinett SR, Wylie N, Boyle AWR, Bekaii-Saab TS, Gores GJ, Smoot R, Barrett M, Nagalo B, Meurice N, Elliott N, Petit J, Zhou Y, Arora M, Dumbauld C, Barro O, Baker A, Bogenberger J, Buetow K, Mansfield A, Mody K, Borad MJ. Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO Precis Oncol. 2022 06; 6:e2100274.
    View in: PubMed
    Score: 0.008
  19. Arora M, Bogenberger JM, Abdelrahman AM, Yonkus J, Alva-Ruiz R, Leiting JL, Chen X, Serrano Uson Junior PL, Dumbauld CR, Baker AT, Gamb SI, Egan JB, Zhou Y, Nagalo BM, Meurice N, Eskelinen EL, Salomao MA, Kosiorek HE, Braggio E, Barrett MT, Buetow KH, Sonbol MB, Mansfield AS, Roberts LR, Bekaii-Saab TS, Ahn DH, Truty MJ, Borad MJ. Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers. Hepatology. 2022 01; 75(1):43-58.
    View in: PubMed
    Score: 0.008
  20. Uson Junior PLS, DeLeon TT, Bogenberger JM, Pai RK, Kosiorek HE, Yin J, Ahn DH, Sonbol MB, Bekaii-Saab T, Mansfield AS, Buetow K, Gores GJ, Smoot R, Vasmatzis G, Kipp BR, Mahipal A, Baker AT, Babiker H, Barro O, Dumbauld C, Zhou Y, Aslam FN, Barrett M, Jacobs B, Meurice N, Arora M, Petit J, Elliott N, Nagalo B, Salomao MA, Borad MJ. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations. Dig Dis Sci. 2022 08; 67(8):3797-3805.
    View in: PubMed
    Score: 0.008
  21. Uson Junior PLS, Nagalo BM, Ahn DH, Bekaii-Saab T, Borad MJ. Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently? Semin Liver Dis. 2021 05; 41(2):136-141.
    View in: PubMed
    Score: 0.008
  22. Roy T, Boateng ST, Banang-Mbeumi S, Singh PK, Basnet P, Chamcheu RN, Ladu F, Chauvin I, Spiegelman VS, Hill RA, Kousoulas KG, Nagalo BM, Walker AL, Fotie J, Murru S, Sechi M, Chamcheu JC. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers. Bioorg Chem. 2021 02; 107:104595.
    View in: PubMed
    Score: 0.008
  23. Arora M, Bogenberger JM, Abdelrahman A, Leiting JL, Chen X, Egan JB, Kasimsetty A, Lenkiewicz E, Malasi S, Uson PLS, Nagalo BM, Zhou Y, Salomao MA, Kosiorek HE, Braggio E, Barrett MT, Truty MJ, Borad MJ. Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer. Cancer Chemother Pharmacol. 2020 06; 85(6):1063-1078.
    View in: PubMed
    Score: 0.007
  24. Bayala B, Coulibaly AY, Djigma FW, Nagalo BM, Baron S, Figueredo G, Lobaccaro JA, Simpore J. Chemical composition, antioxidant, anti-inflammatory and antiproliferative activities of the essential oil of Cymbopogon nardus, a plant used in traditional medicine. Biomol Concepts. 2020 Apr 15; 11(1):86-96.
    View in: PubMed
    Score: 0.007
  25. Sombi? HK, Sorgho AP, Kologo JK, Ouattara AK, Yam?ogo S, Yonli AT, Djigma FW, Tchelougou D, Somda D, Kiendr?b?ogo IT, Bado P, Nagalo BM, Nagabila Y, Adoko ETHD, Zabsonr? P, Millogo H, Simpor? J. Glutathione S-transferase M1 and T1 genes deletion polymorphisms and risk of developing essential hypertension: a case-control study in Burkina Faso population (West Africa). BMC Med Genet. 2020 03 19; 21(1):55.
    View in: PubMed
    Score: 0.007
  26. Sorgho PA, Djigma FW, Martinson JJ, Yonli AT, Nagalo BM, Compaore TR, Diarra B, Sombie HK, Simpore A, Zongo AW, Ouattara AK, Soubeiga STR, Traore L, Yelemkoure ET, Kiendrebeogo IT, Roberts LR, Simpore J. Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso. Biomol Concepts. 2019 Dec 19; 10(1):226-236.
    View in: PubMed
    Score: 0.007
  27. Sombi? HK, Kologo JK, Tchelougou D, Ou?draogo SY, Ouattara AK, Compaor? TR, Nagalo BM, Sorgho AP, Nagabila I, Soube?ga ST, Djigma FW, Yonli AT, Zabsonr? P, Millogo H, Simpor? J. Positive association between ATP2B1 rs17249754 and essential hypertension: a case-control study in Burkina Faso, West Africa. BMC Cardiovasc Disord. 2019 06 26; 19(1):155.
    View in: PubMed
    Score: 0.007
  28. Bisseye C, Eko Mba JM, Ntsame Ndong JM, Kosiorek HE, Butterfield RJ, Mombo LE, M'batchi B, Borad MJ, Nagalo BM, Allain JP. Decline in the seroprevalence of syphilis markers among first-time blood donors in Libreville (Gabon) between 2004 and 2016. BMC Public Health. 2019 Feb 08; 19(1):167.
    View in: PubMed
    Score: 0.007
  29. DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ. Novel immunotherapy strategies for hepatobiliary cancers. Immunotherapy. 2018 09; 10(12):1077-1091.
    View in: PubMed
    Score: 0.006
  30. Sanou M, Soubeiga ST, Bationo F, Compaore TR, Zohoncon TM, Diatto GN, Ouedraogo P, Pietra V, Nagalo BM, Bisseye C, Traore RO, Simpore J. A decade of follow-up and therapeutic drug monitoring in HIV-2 immunocompromised patients at St Camille and General Lamizana Military Medical Centers, Burkina Faso, West Africa. Pak J Biol Sci. 2014 Dec; 17(12):1219-24.
    View in: PubMed
    Score: 0.005
  31. Simpore A, Bisseye C, Nagalo BM, Sanou M, N?bi? Y, Ghoma-Linguissi LS, Dahourou H, Sawadogo B, Djigma F, Ouattara S, Pietra V, Nichol J, Simpore J. Importance of extending the use of polymerase chain reaction in the diagnosis of venereal syphilis in a blood transfusion center in Burkina Faso, West Africa. Pan Afr Med J. 2014; 18:56.
    View in: PubMed
    Score: 0.005
  32. Sanou M, Ky A, Ouangre E, Bisseye C, Sanou A, Nagalo BM, Sanou D, Simpor? J, Sangare L, Traore R. [Characterization of bacterial flora in community peritonitis carried out in Burkina Faso]. Pan Afr Med J. 2014; 18:17.
    View in: PubMed
    Score: 0.005
  33. Zeba MT, Sanou M, Bisseye C, Kiba A, Nagalo BM, Djigma FW, Compaor? TR, Nebi? YK, Kienou K, Sagna T, Pietra V, Moret R, Simpor? J. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso. Blood Transfus. 2014 Jan; 12 Suppl 1:s54-7.
    View in: PubMed
    Score: 0.005
  34. Bisseye C, Sanou M, Nagalo BM, Kiba A, Compaor? TR, Tao I, Simpore J. Epidemiology of syphilis in regional blood transfusion centres in Burkina Faso, West Africa. Pan Afr Med J. 2013; 16:69.
    View in: PubMed
    Score: 0.005
  35. Sanou M, Palenfo D, Bisseye C, Nagalo BM, Simpor? J, Sangar? L, Traor? R. [Molecular diagnosis of bacterial meningitis in Burkina Faso]. Med Sante Trop. 2013 Jan-Mar; 23(1):93-9.
    View in: PubMed
    Score: 0.004
  36. Linguissi LS, Bisseye C, Sagna T, Nagalo BM, Ouermi D, Djigma FW, Pignatelli S, Sia JD, Pietra V, Moret R, Nikiema JB, Simpore J. Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa. Asian Pac J Trop Med. 2012 Dec; 5(12):991-4.
    View in: PubMed
    Score: 0.004
  37. Linguissi LS, Nagalo BM, Bisseye C, Kagon? TS, Sanou M, Tao I, Benao V, Simpor? J, Kon? B. Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso. Asian Pac J Trop Med. 2012 Oct; 5(10):810-3.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.